N/A
N=31
Coaching for HCV and HIV
Hepatitis C · HIV Infections · Opioid-use Disorder
Bottom Line
View on ClinicalTrials.gov: NCT04314414 ↗Enrolled (actual)
31
Serious AEs
0.0%
Results posted
Dec 2022
Primary outcome: Primary: Acceptability of Intervention — 13; 6; 0; 0 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- PRC brief motivational interview intervention (Other); Phone contact (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Boston Medical Center
- Primary completion
- Jan 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Acceptability of Intervention |
13; 6; 0; 0; 1; 16 | — |
| SECONDARY Participant Linkage to HIV Care |
9; 5; 2; 0; 0; 12 | — |
| SECONDARY Participant Linkage to HCV Care |
0; 2 | — |
| SECONDARY Participant Linkage to Care for Opioid Use |
10; 6; 0; 0; 0; 15 | — |
| SECONDARY Number of Participants Who Received Pre-exposure Prophylaxis (PrEP) |
5; 6 | — |
| SECONDARY Number of Participants Who Received HCV Care |
0; 2 | — |
| SECONDARY Number of Participants Who Received Opioid Use Treatment |
22; 6; 15; 13 | — |
Summary
The objective of this study is to determine the feasibility and acceptability of a peer recovery coach (PRC) intervention to improve linkage to hepatitis C (HCV) and/or human immunodeficiency virus (HIV) care, treatment initiation, and evaluation for HIV pre-exposure prophylaxis (PrEP) (when applicable) among individuals with a history of opioid use disorder accessing a substance use low-barrier-to-access (LBA) walk-in clinic.
In-depth interviews will be administered to participants at baseline, three- and six-months for study participants (40 total participants). The investigator will also follow-up with the per recovery coach and administer surveys to assess the feasibility of a peer recovery coaching intervention in improving HCV/HIV related linkage to care and management. Patient medical records and peer recovery coach monthly reports will be accessed and reviewed to determine fidelity to research protocols.
Eligibility Criteria
Inclusion Criteria
- Individuals with opioid use disorder, non-reactive HIV antibody test and reactive HCV antibody testing at the BMC LBA walk-in clinic
- Able to speak English
- Individuals providing contact information of two family members or friends
- Individuals signing a medical records release form
Exclusion Criteria
- Individuals already linked to substance use care
- Individuals co-infected with HIV and HCV and engaged in care
Data sourced from ClinicalTrials.gov (NCT04314414). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.